MC
TTOO

Moors & Cabot’s T2 Biosystems, Inc TTOO Stock Holding History

Moors & Cabot’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2
Closed -$1K – 892
2022
Q3 		$1K Hold
2
– – ﹤0.01% 821
2022
Q2 		$2K Sell
2
-1
-33% -$1.48K ﹤0.01% 811
2022
Q1 		$7K Hold
3
– – ﹤0.01% 863
2021
Q4 		$7K Buy
+3
New +$10.4K ﹤0.01% 869

Other funds holding TTOO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ML
McAdam LLC Philadelphia, Pennsylvania $2.22B AUM 16.98% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Moors & Cabot's TTOO Position: Q4 2022 in Review

Moors & Cabot sold out of T2 Biosystems, Inc (TTOO) in Q4 2022, closing a stake of 2 shares — an estimated $1K sold.

Moors & Cabot first reported a position in TTOO in Q4 2021 and held it in 4 quarters. The position peaked at $7K in Q1 2022. 20 funds tracked by Wall St. Rank hold TTOO as of Q4 2022.

  • Moors & Cabot reported no remaining T2 Biosystems, Inc position as of Q4 2022 after selling out during the quarter.
  • Moors & Cabot sold 2 T2 Biosystems, Inc shares in Q4 2022, an estimated $1K.
  • Moors & Cabot first reported a position in T2 Biosystems, Inc in Q4 2021 and held it in 4 quarters.
  • Moors & Cabot's T2 Biosystems, Inc position peaked at $7K in Q1 2022.
  • 20 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2022.

Based on Moors & Cabot's 13F filing for Q4 2022, filed 7 Feb 2023.